How to Validate Your Antibodies

Abstract

Get full access to this article

View all access options for this article.

References

Elliott

et al., “Anti-Epo Receptor Antibodies Do Not Predict Epo Receptor Expression,” Blood , 107(3), 454 (2006).

Patterson

S.D.

et al., “Functional EPOR Pathway Utilization Is Not Detected in Primary Tumor Cells Isolated from Human Breast, Non-Small Cell Lung, Colorectal, and Ovarian Tumor Tissues,” PLOS One , 10, e0122149 (2015).

Endre

Z.H.

et al., “Early Intervention with Erythropoietin Does Not Affect the Outcome of Acute Kidney Injury (The EARLYARF Trial),” Kidney Int. , 77(11), 1020–1030. doi: 10.1038/ki.2010.25 (2006).

Elliott

et al., “Lack of Expression and Function of Erythropoietin Receptors in the Kidney,” Nephrol. Dial. Transplant. , 27, 2733–2745, doi: 10.1093/ndt/gfr698 (2012).

Hodgson

, “Guest Post: Finding the Perfect Antibody,” Science Exchange , blog.scienceexchange.com/2012/03/guest-post-alexandra-hodgson/, accessed December 6, 2017.

Bogoev

, “The Antibody Challenge: Bio-Rad’s Precise Solution,” Bioradiations , www.bioradiations.com/the-antibody-challenge-bio-rads-precise-solution, accessed December 6, 2017.

Freedman

L.P.

et al., “Letter to the Editor: The Need for Improved Education and Training in Research Antibody Usage and Validation Practices,” Biotechniques , 61, 16–18, doi: 10.2144/000114431 (2015).

Welsh

A.W.

et al., “Standardization of Estrogen Receptor Measurement in Breast Cancer Suggests False-Negative Results are a Function of Threshold Intensity Rather than Percentage of Positive Cells,” J. Clin. Oncol. , 29(22), 2978–2984 (2011).